✦ LIBER ✦

The Efficacy of Additional Bevacizumab to Cytotoxic Chemotherapy Regimens for the Treatment of Colorectal Cancer: An Updated Meta-Analysis for Randomized Trials

✍ Scribed by Lv, Chao; Wu, Shuodong; Zheng, Duo; Wu, Yuli; Yao, Dianbo; Yu, Xiaopeng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Magnitude of benefit of the addition of

✍ Fotios Loupakis, Emilio Bria, Vanja Vaccaro… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 544 KB

Overall survival benefits for irinotecan

✍ Wei-Xiang Qi; Zan Shen; Feng Lin; Yuan-Jue Sun; Da-Liu Min; Li-Na Tang; Ai-Na He 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 697 KB

6051 Balancing pros and cons of the addi

✍ Cuppone, F.; Vaccaro, V.; Loupakis, F.; Milella, M.; Carlini, P.; Nisticò, C.; F 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Peri-operative chemotherapy for the trea

✍ Martina Wieser; Stefan Sauerland; Dirk Arnold; Wolff Schmiegel; Anke Reinacher-S 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 1013 KB

The efficacy of bevacizumab plus paclita

✍ Wang, Xuan; Huang, Chun; Li, Man; Gu, Yanjun; Cui, Yanfen; Li, Yan 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 395 KB

Combined Analysis of Efficacy: The Addit

✍ Kabbinavar, F. F. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB